THE INFLUENCE OF TISSUE ANGIOTENSINS ON ELEMENTS OF THE CARDIOVASCULAR SYSTEM (LECTURE)

Relevance. The renin-angiotensin system is today one of the oldest and most studied peptide cascades. Understanding the operation of this system is an urgent task for study in medical higher education institutions. The renin-angiotensin system is an important regulatory system that supports the metabolism and functioning of many organs, including blood vessels and the myocardium. Since cardiovascular diseases are the main cause of mortality, the study of positive and negative mechanisms of regulation of the cardiovascular system is an urgent task at the present stage.

Aim. Consider modern ideas about the renin-angiotensin system and its role in the regulation of homeostasis.

Results. The lecture discusses the classical and tissue renin-angiotensin system, the main angiotensin metabolites, the pathways of their formation and the enzymes that catalyze these transformations. The effects realized by angiotensins through various receptors are shown. The modern point of view on the levels of organization of the renin-angiotensin system in the body and the relationship of various angiotensin antagonists with each other is considered.

Conclusion. The renin-angiotensin system is one of the most complex systems of hormonal regulation, including several organs that interact to regulate many body functions. The effects of angiotensins are complex and often opposite. An imbalance in the regulation of angiotensin homeostasis leads to metabolic disorders of organs and tissues and manifests itself in pathologies in which inflammatory, hypertrophic and fibrotic phenomena are common, and are also associated with the development of chronic diseases affecting various organs and tissues of the body.

1. Fyhrquist F., Saijonmaa O. Renin-angiotensin system revisited. J. Intern. Med. 2008; 264(3): 224–236. DOI: 10.1111/j.1365-2796.2008.01981.x

2. Fountain J.H., Kaur J., Lappin S.L. Physiology, Renin Angiotensin System. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

3. Максимов М.Л., Дралова О.В., Стародубцев А.К. Антагонисты АТ1-рецепторов ангиотензина II, ингибиторы ангиотензинпревращающего фермента в регуляции гемодинамики и активности ангиотензин-альдостероновой системы. Фокус на органопротективные эффекты. Кардиоваскулярная терапия и профилактика. 2010;9(2):115-124 [Maksimov M.L., Dralova O.V., Starodubtsev A.K. Antagonists of AT1 receptors of angiotensin II, inhibitors of angiotensin-converting enzyme in the regulation of hemodynamics and the activity of the angiotensin-aldosterone system. Focus on organoprotective effects. Cardiovascular therapy and prevention. 2010 9(2):115-124 (In Russian)]. https://cardiovascular.elpub.ru/jour/article/view/2055/1710?locale=ru_RU [дата доступа: 21.05.2024].

4. Vargas Vargas R.A., Varela Millán J.M., Fajardo Bonilla E. Renin-angiotensin system: Basic and clinical aspects-A general perspective. Endocrinol Diabetes Nutr (Engl Ed). 2022;(1):52-62. DOI: 10.1016/j.endien.2022.01.005

5. van Kats J.P., de Lannoy L.M., Jan Danser A.H. et al. Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension. 1997;30(1 Pt 1):42-49. DOI: 10.1161/01.hyp.30.1.42

6. Carey R.M., Wang Z.Q., Siragy H.M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 2000;35(1 Pt 2): 155-163. DOI: 10.1161/01.hyp.35.1.155

7. Kaschina E., Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12(2):70-88. DOI: 10.1080/08037050310001057

8. Eguchi S., Kawai T., Scalia R., Rizzo V. Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology. Hypertension. 2018;71(5):804-810. DOI: 10.1161/HYPERTENSIONAHA.118.10266

9. Capric V., Chandrakumar H.P., Celenza-Salvatore J.N., Makaryus A. The Role of the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease: Pathogenetic Insights and Clinical Implications. Renin-Angiotensin Aldosterone System. IntechOpen; 2021. Available from: doi.org/10.5772/intechopen.

10. Holst J.P., Soldin O.P., Guo T., Soldin S.J. Steroid hormones: relevance and measurement in the clinical laboratory. Clin Lab Med. 2004;24(1):105-118. DOI: 10.1016/j.cll.2004.01.004

11. Paul M., Poyan Mehr A., Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747-803. DOI: 10.1152/physrev.00036.2005

12. Pacurari M., Kafoury R., Tchounwou P.B., Ndebele K. The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam. 2014;2014: 689360. DOI: 10.1155/2014/689360

13. Ahmad S., Varagic J., Groban L. et al. Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. Curr Hypertens Rep. 2014;16(5):429. DOI: 10.1007/s11906-014-0429-9

14. Esser N., Zraika S. Neprilysin Inhibitors and Angiotensin (1-7) in COVID-19. Br J Cardiol. 2020;27(4):109-111. DOI: 10.5837/bjc.2020.031

15. Yu L., Yuan K., Phuong H.T. et al. Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor. Peptides. 2016;86:33-41. DOI: 10.1016/j.peptides.2016.09.009

16. Varagic J., Ahmad S., Nagata S., Ferrario C.M. ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury. Curr Hypertens Rep. 2014;16(3):420. DOI: 10.1007/s11906-014-0420-5

17. Martyniak A., Tomasik P.J. A New Perspective on the Renin-Angiotensin System. Diagnostics (Basel). 2022;13(1):16. DOI: 10.3390/diagnostics13010016

18. Januzzi J.L. Jr, Ibrahim N.E. Renin-Angiotensin System Blockade in Heart Failure: More to the Picture Than Meets the Eye. J Am Coll Cardiol. 2017;69(7):820-822. DOI: 10.1016/j.jacc.2016.10.083

19. Paz Ocaranza M., Riquelme J.A., García L. et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17(2):116-129. DOI: 10.1038/s41569-019-0244-8

20. Kaschina E., Unger T. Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function. Blood Pressure. 2009;12:2:70-88. DOI: 10.1080/08037050310001057

21. van Thiel B.S., van der Pluijm I., te Riet L. et al. The renin-angiotensin system and its involvement in vascular disease. Eur J Pharmacol. 2015;763(Pt A):3-14. DOI: 10.1016/j.ejphar.2015.03.090

22. Verma K., Pant M., Paliwal S. et al. An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Front Pharmacol. 2021;12:734917. DOI: 10.3389/fphar.2021.734917

23. Beyazit Y., Purnak T., Guven G.S., Haznedaroglu I.C. Local bone marrow Renin-Angiotensin system and atherosclerosis. Cardiol Res Pract. 2010;2011:714515. DOI: 10.4061/2011/714515

24. Flores-Monroy J., Lezama-Martínez D., Martínez-Aguilar L. Function of renin angiotensin system on heart failure. Journal of Integrative Cardiology. 2016;2(5): 380386. DOI: 10.15761/JIC.1000180

25. Padia S.H., Carey R.M. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch. 2013;465(1):99-110. DOI: 10.1007/s00424-012-1146-3

26. Patel V.B., Zhong J.C., Grant M.B., Oudit G.Y. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure. Circ Res. 2016;118(8):1313-1326. DOI: 10.1161/CIRCRESAHA.116.307708

27. Suzuki S., Iida M., Hiroaki Y. et al. Structural insight into the activation mechanism of MrgD with heterotrimeric Gi-protein revealed by cryo-EM. Commun Biol. 2022;5:707. DOI: 10.1038/s42003-022-03668-3

28. Poznyak A.V., Bharadwaj D., Prasad G. et al. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. Int J Mol Sci. 2021;22(13):6702. DOI: 10.3390/ijms22136702

29. Mehta J.K., Kaur G., Buttar H.S. et al. Role of the renin–angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products. Front. Physiol. Sec. Vascular Physiology. 2023;14. DOI:10.3389/fphys.2023.1034170

30. Turner A.J. ACE2 Cell Biology, Regulation, and Physiological Functions. The Protective Arm of the Renin Angiotensin System (RAS). 2015;185-189. DOI:10.1016/B978-0-12-801364-9.00025-0

31. Doggrell S.A., Wanstall J.C. Vascular chymase: pathophysiological role and therapeutic potential of inhibition, Cardiovascular Research. 2004;61(4):653-662. DOI:10.1016/j.cardiores.2003.11.029

32. Tchougounova E., Lundequist A., Fajardo I. et al. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 2005;280:9291–9296. DOI: 10.1074/jbc.M410396200